Avantax Advisory Services’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-9,728
Closed -$230K – 1542
2022
Q4
$230K Sell
9,728
-2,257
-19% -$60.9K ﹤0.01% 1242
2022
Q3
$304K Sell
11,985
-188
-2% -$6.59K ﹤0.01% 1005
2022
Q2
$404K Buy
12,173
+3,116
+34% +$132K 0.01% 874
2022
Q1
$653K Buy
9,057
+784
+9% +$56.5K 0.01% 690
2021
Q4
$760K Sell
8,273
-514
-6% -$61.4K 0.01% 611
2021
Q3
$1.11M Buy
8,787
+364
+4% +$53K 0.02% 458
2021
Q2
$1.39M Buy
8,423
+770
+10% +$125K 0.03% 404
2021
Q1
$1.39M Buy
7,653
+608
+9% +$141K 0.03% 367
2020
Q4
$1.41M Sell
7,045
-6,031
-46% -$1.23M 0.03% 327
2020
Q3
$2.86M Buy
13,076
+7,308
+127% +$1.55M 0.05% 294
2020
Q2
$1.1M Sell
5,768
-19,981
-78% -$3.5M 0.03% 324
2020
Q1
$4M Sell
25,749
-296
-1% -$34.4K 0.12% 118
2019
Q4
$2.18M Buy
26,045
+5,856
+29% +$446K 0.05% 193
2019
Q3
$1.37M Buy
+20,189
New +$1.33M 0.06% 169

Other funds holding TDOC

Avantax Advisory Services's TDOC Position: Q1 2023 in Review

Avantax Advisory Services sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 9,728 shares — an estimated $230K sold.

Avantax Advisory Services first reported a position in TDOC in Q3 2019 and held it in 14 quarters. The position peaked at $4M in Q1 2020. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Avantax Advisory Services reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Avantax Advisory Services sold 9,728 Teladoc Health shares in Q1 2023, an estimated $230K.
  • Avantax Advisory Services first reported a position in Teladoc Health in Q3 2019 and held it in 14 quarters.
  • Avantax Advisory Services's Teladoc Health position peaked at $4M in Q1 2020.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Avantax Advisory Services's 13F filing for Q1 2023, filed 28 Apr 2023.